Uninhibited' price hikes, lobbying and more: Congressional probe gives detailed look into Teva's long run with Copaxone | Fierce Pharma
In this photo illustration a Teva logo is displayed on a smartphone with stock market percentages on the background. (Photo by Omar Marques / SOPA Images/Sipa USA Stock Photo - Alamy
Teva 'Plagued By Problems,' Downgraded On Lost MS Drug Patents, DOJ Probe | Stock News & Stock Market Analysis - IBD